Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Levels of blood-coagulation factors during anticoagulant therapy with phenindione.

Literature DB >> 13721922

Levels of blood-coagulation factors during anticoagulant therapy with phenindione.

K W DENSON.

Abstract

Entities: Chemical

Keywords: BLOOD COAGULATION; PHENINDIONE/pharmacology

Mesh：

Substances：

Year: 1961 PMID： 13721922 PMCID： PMC1954066 DOI： 10.1136/bmj.1.5234.1205

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

× No keyword cloud information.

20 in total

1. Christman-factor (factor IX) deficiency produced by concurrent administration of heparin with coumarin drugs.

Authors: H B GREIG
Journal: Lancet Date: 1959-07-11 Impact factor: 79.321

2. The behaviour of coagulation factors during anticoagulant therapy with special reference to the one-stage test as an index of therapy.

Authors: N D HICKS; J A BONNIN
Journal: Br J Haematol Date: 1959-04 Impact factor: 6.998

3. [The Stuart factor during coumarin therapy].

Authors: M H HORDER
Journal: Thromb Diath Haemorrh Date: 1958-05-01

4. Factor VII; its turnover rate and its possible role in thrombogenesis.

Authors: E A LOELIGER; C ter HAAR; H L BOOIJ
Journal: Thromb Diath Haemorrh Date: 1960-03-01

5. Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency.

Authors: C HOUGIE; E M BARROW; J B GRAHAM
Journal: J Clin Invest Date: 1957-03 Impact factor: 14.808

6. Electrophoretic studies of the Prower factor; a blood coagulation factor which differs from factor VII.

Authors: K W DENSON
Journal: Br J Haematol Date: 1958-07 Impact factor: 6.998

7. Owren's method for the control of anticoagulant therapy.

Authors: M J ALLINGTON
Journal: J Clin Pathol Date: 1958-01 Impact factor: 3.411

8. A new coagulation defect.

Authors: T P TELFER; K W DENSON; D R WRIGHT
Journal: Br J Haematol Date: 1956-07 Impact factor: 6.998

9. Mode of action of coumarin drugs.

Authors: A S DOUGLAS
Journal: Br Med Bull Date: 1955 Impact factor: 4.291

10. Action of coumarin anticoagulants on a possible new serum clotting factor.

Authors: W WALKER; R B HUNTER
Journal: Nature Date: 1954-06-19 Impact factor: 49.962

8 in total

1. Dilution curve studies in prothrombin complex factors deficiencies and abnormalities.

Authors: A Girolami; A Brunetti; L DeMarco; D Fioretti
Journal: Blut Date: 1974-08

2. Comparison of two laboratory tests in the control of anticoagulant therapy.

Authors: S J Pearce; A S Sekar
Journal: J Clin Pathol Date: 1973-01 Impact factor: 3.411

3. Factor X level in coumarin treated patients and in factor X deficiency as assayed with different techniques.

Authors: A Girolami; A Brunetti; G Bareggi
Journal: Blut Date: 1972-08

4. Improved control of long-term anticoagulant therapy.

Authors: R D Eastham
Journal: Br Med J Date: 1968-05-11

5. Coagulation factor analysis in patients on long-term anticoagulation.

Authors: H A Perkins; R L Biben
Journal: Calif Med Date: 1970-03

6. Coagulation factors in chronic liver disease.

Authors: G W Donaldson; S H Davies; A Darg; J Richmond
Journal: J Clin Pathol Date: 1969-03 Impact factor: 3.411

7. Maintenance control of oral anticoagulant therapy by a chromogenic substrate assay for factor X.

Authors: J G Erskine; I D Walker; J F Davidson
Journal: J Clin Pathol Date: 1980-05 Impact factor: 3.411

8. The K-test (trypsin clotting time) in coumarin treated patients and in congenital deficiencies and abnormalities of the prothrombin complex.

Authors: A Girolami; A Brunetti; G Patrassi; F Cafiero
Journal: Blut Date: 1975-11

8 in total